Is Estrella Immunopharma Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: ESLA) stock is to Strong Buy ESLA stock.
Out of 1 analyst, 1 (100%) are recommending ESLA as a Strong Buy, 0 (0%) are recommending ESLA as a Buy, 0 (0%) are recommending ESLA as a Hold, 0 (0%) are recommending ESLA as a Sell, and 0 (0%) are recommending ESLA as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year ESLA price target, the average ESLA price target is $16.00, with the highest ESLA stock price forecast at $16.00 and the lowest ESLA stock price forecast at $16.00.
The Wall Street analyst predicted that Estrella Immunopharma's share price could reach $16.00 by Feb 21, 2026. The average Estrella Immunopharma stock price prediction forecasts a potential upside of 1,500% from the current ESLA share price of $1.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.